ARCHIVES

NCI To Offer Expanded Access To Oxaliplatin

This article is from The Cancer Letter archive.

Vol. 28 No. 22 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

October 25, 1985

Human Embryo Panel Defines Acceptable Research For Funding

September 30, 1994

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

June 22, 2012

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983